![Argeris Karabelas](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Argeris Karabelas
Direktor/Vorstandsmitglied bei
REGENXBIO INC.
Vermögen: 202 316 $ am 31.05.2026
Profil
Argeris N.
Karabelas founded Vanda Pharmaceuticals, Inc. in 2002, where he worked as Independent Director from 2011 to 2012 and Novartis Bioventure Fund in 2000, where he worked as Chairman from 2000 to 2001.
Dr. Karabelas also founded CytoTherapuetics, Inc., Somnus Therapeutics, Inc., Minerva Neurosciences, Inc., and various other companies.
Dr. Karabelas also currently works at Clinical Development Capital LLC, as Chief Executive Officer, Inoteck, Inc., as Chairman, REGENXBIO, Inc., as Independent Director from 2024, and various other companies.
Dr. Karabelas also formerly worked at Novartis AG, as CEO-Pharmaceuticals & Head-Healthcare Division from 1998 to 2000, Ciba Vision Corp., as Chief Executive Officer, Novartis Pharma AG, as CEO-Worldwide Pharmaceuticals & Head-Healthcare from 1998 to 2000, and various other companies.
Dr. Karabelas received his doctorate degree from Massachusetts College of Pharmacy & Health Science and undergraduate degree from the University of New Hampshire.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
REGENXBIO, INC. 0.06% | 29.05.2026 | 28’861 ( 0.06% ) | 202 316 $ | 31.05.2026 |
Aktive Positionen von Argeris Karabelas
| Unternehmen | Position | Beginn |
|---|---|---|
| REGENXBIO INC. | Direktor/Vorstandsmitglied | 01.05.2015 |
| BRAEBURN INC. | Direktor/Vorstandsmitglied | 01.09.2015 |
Care Capital II LLC | Corporate Officer/Principal | - |
Care Capital III LLC | Corporate Officer/Principal | - |
Broadview Ventures, Inc.
 Broadview Ventures, Inc. Investment ManagersFinance Broadview Ventures invests in companies located across the globe, primarily in North America, Europe and Israel. The firm targets companies operating in the fields of healthcare and technology sectors. It provides financing for seed and early-stage capital requirements. The firm makes follow-on investments. | Berater | - |
Clinical Development Capital LLC
 Clinical Development Capital LLC Finance/Rental/LeasingFinance Provides funding for ethical drug clinical trials | Vorstandsvorsitzender | - |
Inoteck, Inc. | Vorsitzender | - |
Apple Tree Venture Management Llc//vc
 Apple Tree Venture Management Llc//vc Investment ManagersFinance Apple Tree Partners invests in companies located in the United States. The firm focuses on the life sciences sector. It provides financing for seed, early and later stage capital requirements. | Private Equity Investor | - |
Ehemalige bekannte Positionen von Argeris Karabelas
| Unternehmen | Position | Ende |
|---|---|---|
| BAUSCH HEALTH COMPANIES INC. | Direktor/Vorstandsmitglied | 16.05.2023 |
| ░░░░ ░░░░░░░ ░░░ | ░░░░░░░ ░░░░░░ ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░ | ░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░░░░░░░ ░░░░░ | ░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von Argeris Karabelas
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
69
Beziehungen ersten Grades
41
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 41 |
|---|---|
Bausch Health Americas, Inc.
 Bausch Health Americas, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceuticals | Health Technology |
Acura Pharmaceuticals, Inc.
 Acura Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical ingredients | Health Technology |
Human Genome Sciences, Inc.
 Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Provides pharmaceutical and diagnostic products | Health Technology |
SkyePharma Plc
 SkyePharma Plc Pharmaceuticals: OtherHealth Technology Manufactures and develops oral and inhalation pharmaceutical products | Health Technology |
NitroMed, Inc.
 NitroMed, Inc. Pharmaceuticals: MajorHealth Technology Develops and supplies pharmaceuticals | Health Technology |
Anadys Pharmaceuticals, Inc.
 Anadys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures novel small molecule medicines | Health Technology |
Inotek Pharmaceuticals Corp.
 Inotek Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Engages in the development, discovery and commercialization of therapies for glaucoma and other diseases of the eye | Health Technology |
Vanda Pharmaceuticals, Inc.
 Vanda Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company, which focuses on the development and commercialization of therapies | Health Technology |
NormOxys, Inc.
 NormOxys, Inc. Pharmaceuticals: MajorHealth Technology Develops small-molecule therapeutics for the treatment of cancer | Health Technology |
REGENXBIO, Inc.
 REGENXBIO, Inc. Pharmaceuticals: MajorHealth Technology Develops gene therapy | Health Technology |
Novartis AG
 Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
GSK Plc
 GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
Minster Pharmaceuticals Plc
 Minster Pharmaceuticals Plc Pharmaceuticals: MajorHealth Technology Develops pharmaceutical compounds for the treatment of neurological and psychiatric conditions | Health Technology |
Care Capital LLC
 Care Capital LLC Investment ManagersFinance Care capital invests in companies located in the United States. The firm targets companies operating in the fields of biotechnology and specialty pharmaceuticals. It provides financing for growth and buyout capital transactions with an investment size of USD 5 - 20 million. | Finance |
Novartis Pharma Schweiz AG
 Novartis Pharma Schweiz AG Miscellaneous Commercial ServicesCommercial Services Researches and develops vaccines for viral diseases | Commercial Services |
Ciba Vision Corp.
 Ciba Vision Corp. Electronic ComponentsElectronic Technology Manufactures eyeglasses, contact lenses and lens care products | Electronic Technology |
Renovo Ltd.
 Renovo Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
CytoTherapuetics, Inc.
 CytoTherapuetics, Inc. Financial ConglomeratesFinance Biological Products | Finance |
Massachusetts College of Pharmacy & Health Science
 Massachusetts College of Pharmacy & Health Science Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Massachusetts
 University of Massachusetts Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of New Hampshire
 University of New Hampshire Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of the Sciences in Philadelphia
 University of the Sciences in Philadelphia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Fox Chase Cancer Center
 The Fox Chase Cancer Center Hospital/Nursing ManagementHealth Services Owns and operates hospitals | Health Services |
Novartis Venture Funds
 Novartis Venture Funds Investment ManagersFinance NVF invests in companies located across North America and Europe. The firm focuses on biotechnology & biopharmaceutical and Life science sectors. It provides financing for early and later stage transactions with an investment size up to USD 30 million per company and also acts as lead or co-lead investor. The firm takes a seat on the board of directors. | Finance |
Care Capital II LLC | |
Spexis Ltd.
 Spexis Ltd. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that focuses on the discovery and development of macrocycle drugs addressing unmet medical needs | Health Technology |
Clinical Development Capital LLC
Clinical Development Capital LLC Finance/Rental/LeasingFinance Provides funding for ethical drug clinical trials | Finance |
Apple Tree Venture Management Llc//vc
Apple Tree Venture Management Llc//vc Investment ManagersFinance Apple Tree Partners invests in companies located in the United States. The firm focuses on the life sciences sector. It provides financing for seed, early and later stage capital requirements. | Finance |
Novartis Bioventure Fund
 Novartis Bioventure Fund Investment ManagersFinance Acts as Venture Capital Fund | Finance |
Inoteck, Inc. | |
Care Capital III LLC | |
Somnus Therapeutics, Inc.
 Somnus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a drug development company | Health Technology |
Cyrenaic Pharmaceuticals, Inc.
 Cyrenaic Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Provides and develops drugs | Health Technology |
Novartis Pharma AG
 Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Health Technology |
Broadview Ventures, Inc.
Broadview Ventures, Inc. Investment ManagersFinance Broadview Ventures invests in companies located across the globe, primarily in North America, Europe and Israel. The firm targets companies operating in the fields of healthcare and technology sectors. It provides financing for seed and early-stage capital requirements. The firm makes follow-on investments. | Finance |
GlaxoSmithKline LLC
 GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology Engages in research and development, manufacturing of respiratory, immunology, oncology and infectious disease medicines and vaccines | Health Technology |
Bausch Health Cos., Inc.
 Bausch Health Cos., Inc. Pharmaceuticals: OtherHealth Technology Manufactures and markets pharmaceutical products | Health Technology |
Edusa Pharmaceuticals, Inc.
 Edusa Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops biotechnology products for the treatment of gastrointestinal disorders | Health Technology |
Smithkline Beecham Pharmaceuticals (Canada) | |
Minerva Neurosciences, Inc.
 Minerva Neurosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and commercializes drugs to treat patients suffering from central nervous system diseases | Health Technology |
Braeburn, Inc.
 Braeburn, Inc. Miscellaneous Commercial ServicesCommercial Services Develops and manufactures pharmaceutical products for opioid use disorder | Commercial Services |
